On Wednesday, Sabra Healthcare REIT reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 82, up from 76 the day before.
Risk Management In The Stock Market: How Much Money To Invest Now
This exclusive rating from Investor's Business Daily measures price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves.
Sabra Healthcare REIT is working on a cup with handle with an 18.32 buy point. See if the stock can clear the breakout price in heavy trade.
The company reported 6% earnings growth in its most recent report, while sales growth came in at 10%.
The company holds the No. 3 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
